Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to $1.8 million.

  • Altimmune's Non Operating Income fell 400.62% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year decrease of 3024.14%. This contributed to the annual value of $8.1 million for FY2024, which is 843.36% up from last year.
  • As of Q3 2025, Altimmune's Non Operating Income stood at $1.8 million, which was down 400.62% from $776000.0 recorded in Q2 2025.
  • In the past 5 years, Altimmune's Non Operating Income ranged from a high of $2.4 million in Q1 2024 and a low of -$306000.0 during Q3 2021
  • Over the past 5 years, Altimmune's median Non Operating Income value was $1.6 million (recorded in 2025), while the average stood at $1.2 million.
  • Per our database at Business Quant, Altimmune's Non Operating Income crashed by 55835.22% in 2021 and then surged by 187037.04% in 2022.
  • Quarter analysis of 5 years shows Altimmune's Non Operating Income stood at -$81000.0 in 2021, then soared by 1870.37% to $1.4 million in 2022, then surged by 38.21% to $2.0 million in 2023, then fell by 14.93% to $1.7 million in 2024, then rose by 9.43% to $1.8 million in 2025.
  • Its Non Operating Income was $1.8 million in Q3 2025, compared to $776000.0 in Q2 2025 and $1.6 million in Q1 2025.